ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Programs Close Amid Gridlock

October 4, 2013

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998

President’s Cancer Panel Seeks Ways to Open Grants For More New Ideas

December 19, 1980

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012